- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hormone Refractory Prostate Cancer in United Kingdom
Total 6898 results
-
University of SouthamptonTerminatedProstate CancerUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustAstraZenecaCompleted
-
Quadram Institute BioscienceClinical Research and Trials Unit (Norfolk & Norwich University Hospital,...Completed
-
University College, LondonUnknown
-
University of CambridgeUnknown
-
University College London HospitalsUnknown
-
University College London HospitalsCompletedProstate CancerUnited Kingdom
-
Cancer Research UKWithdrawnProstate CancerUnited Kingdom
-
University of NebraskaNational Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity College London Hospitals; University of Sheffield; Queen Mary University... and other collaboratorsCompletedProstate CancerUnited Kingdom
-
Prof Janet BrownSheffield Teaching Hospitals NHS Foundation Trust; Weston Park Hospital Cancer...UnknownProstate CancerUnited Kingdom
-
St. Bartholomew's HospitalUnknownProstate CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomAstraZeneca; Astellas Pharma Inc; Prostate Cancer UKTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Bone Metastases | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Soft Tissue MetastasesUnited States
-
Institute of Cancer Research, United KingdomProstate Cancer UKRecruitingProstate CancerUnited Kingdom
-
Hull University Teaching Hospitals NHS TrustCompleted
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni FoundationTerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Metastatic Prostatic Adenocarcinoma | Hormone-Resistant Prostate CancerUnited States
-
Janssen Pharmaceutica N.V., BelgiumCompletedProstate CancerUnited Kingdom, Belgium, Hungary, Germany
-
Corcept TherapeuticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States, United Kingdom
-
University College, LondonUnknownProstate CancerUnited Kingdom
-
Peng Wang, MD PhDWithdrawnMetastatic Hormone-Sensitive Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Prostate | Hormonal CyclingUnited States
-
The Leeds Teaching Hospitals NHS TrustUnknownProstate CancerUnited Kingdom
-
Royal Marsden NHS Foundation TrustUnknownProstate CancerUnited Kingdom
-
University College, LondonCompletedProstate CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; University of Oxford; Queen Mary University... and other collaboratorsRecruitingProstate Cancer | Genetic Counselling | Genetic Markers | Prostate BiopsyUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Cancer Research UK; Ronald and Rita McAulay...Active, not recruitingProstate Cancer in BRCA1 and BRCA2 CarriersUnited Kingdom
-
Lancashire Teaching Hospitals NHS Foundation TrustCompletedProstate Cancer | Radiotherapy Side EffectUnited Kingdom
-
Washington University School of MedicineBristol-Myers Squibb; The Foundation for Barnes-Jewish Hospital; Bavarian Nordic and other collaboratorsCompletedMetastatic Hormone-Sensitive Prostate CancerUnited States
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate CancerFrance, Spain, Canada, Belgium, United Kingdom, United States
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Metastatic Hormone-sensitive Prostate CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University College London HospitalsUnknownSexual Dysfunction | Prostate CancerUnited Kingdom
-
AmgenCompletedCastrate-resistant Prostate CancerUnited Kingdom, Czech Republic
-
University of BirminghamMedical Research Council; Janssen, LP; Department of Health, United KingdomCompleted
-
University College, LondonCompletedProstate Cancer | MR Image Distortion CorrectionUnited Kingdom
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of MiamiNot yet recruitingProstate Cancer | Prostate Adenocarcinoma | Hormone Sensitive Prostate CancerUnited States
-
CCTU- Cancer ThemeJanssen-Cilag Ltd.Completed
-
Cancer Research UKTerminatedProstate CancerUnited Kingdom
-
Swedish Medical CenterRecruitingProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
University of StirlingProstate Cancer UKCompleted
-
Cancer Research UKUnknownProstate CancerUnited Kingdom
-
Royal Surrey County Hospital NHS Foundation TrustCompletedProstatic Neoplasms | Cancer of the ProstateUnited Kingdom
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Institutes of Health (NIH)CompletedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Institute of Cancer Research, United KingdomSun Pharmaceutical Industries LimitedTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
Asana BioSciencesTerminatedProstate Cancer | Cancer of the Prostate | Neoplasms, Prostate | Prostatic Cancer | Neoplasms, Prostatic | Prostate Neoplasms, Castration-resistantUnited States
-
Sally FalkUnknownLung Cancer | Prostate CancerUnited Kingdom
-
Royal Marsden NHS Foundation TrustRecruiting
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomRecruiting